SCHEMBL6173676

SCHEMBL6173676

CC1(Cc2ccnc3cccc(F)c23)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.52
AR P10275 6/20 0.37
KMT2A Q03164 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.32
TRPV3 Q8NET8 3/20 0.31
TYK2 P29597 1/20 0.31
ITGAL P20701 1/20 0.31
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172368 0.91 IGF1R (0.52) IGF1RARKMT2ATP53TSHR
SCHEMBL6172915 0.90 IGF1R (0.51) IGF1RARKMT2ATP53TSHR
SCHEMBL6173567 0.90 IGF1R (0.51) IGF1RARKMT2ATP53TRPV3
SCHEMBL6169082 0.89 IGF1R (0.50) IGF1RARKMT2ATP53TSHR
SCHEMBL6175292 0.87 IGF1R (0.65) IGF1RARKMT2ATP53TSHR
SCHEMBL6171503 0.87 IGF1R (0.65) IGF1RARKMT2ATP53TSHR
SCHEMBL6176318 0.85 IGF1R (0.42) IGF1RAR
Trifluoroacetic Acid SCHEMBL17558350 0.83 IGF1R (0.60) IGF1RARKMT2AITGAL
Trifluoroacetic Acid SCHEMBL17558459 0.83 IGF1R (0.60) IGF1RARKMT2AITGAL
SCHEMBL6174186 0.81 IGF1R (0.51) IGF1RARKMT2ATP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed